How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studies

P. A. Ascierto, A. Marabelle

Résultats de recherche: Contribution à un journal › Editorial

2 Citations (Scopus)

Accès au document

@article{17300d8865014a39a67e225176082b67,

title = "How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studies",

author = "Ascierto, {P. A.} and A. Marabelle",

year = "2018",

month = nov,

day = "1",

doi = "10.1093/annonc/mdy420",

language = "English",

volume = "29",

pages = "2157--2160",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "11",

}

TY - JOUR

T1 - How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studies

AU - Ascierto, P. A.

AU - Marabelle, A.

PY - 2018/11/1

Y1 - 2018/11/1

UR - http://www.scopus.com/inward/record.url?scp=85058609822&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy420

DO - 10.1093/annonc/mdy420

M3 - Editorial

C2 - 30307539

AN - SCOPUS:85058609822

SN - 0923-7534

VL - 29

SP - 2157

EP - 2160

JO - Annals of Oncology

JF - Annals of Oncology

IS - 11

ER -